GlobeImmune's Grant - II Round

GlobeImmune raised a round of funding on September 06, 2013. Investors include National Institute of Allergy and Infectious Diseases.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Grant - II Round: